|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Acute myeloid leukemia - Clinical I |
| Date: |
Friday, 05 June 2009
|
| Time: | 17:45-19:00 |
| Room: | |
| |
| 17:45-19:00 |
|
CONTINUOUS SEQUENTIAL INFUSION OF FLUDARABINE AND CYTARABINE FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) SECONDARY TO MYELODYSPLASTIC SYNDROME (MDS)
| 0300 |
| Ferrara, Felicetto,
Palmieri, Salvatore,
Mele, Giuseppina,
Izzo, Tiziana,
Criscuolo, Clelia,
Pedata, Mariangela,
Riccardi, Cira,
Pocali, Barbara,
Califano, Catello,
D'arco, Alfonso
(Naples, Italy) |
| |
| 17:45-19:00 |
|
INFLUENCE OF HIGH EXPRESSION OF SMAC/DIABLO PROTEIN ON CLINICAL OUTCOME IN ACUTE MYELOID LEUKEMIA PATIENTS
| 0301 |
| Pluta, Agnieszka,
Wrzesien-Kus, Agata,
Cebula, Barbara,
Wolska, Anna,
Szmigielska-Kaplon, Anna,
Robak, Tadeusz,
Smolewski, Piotr,
Wierzbowska, Agnieszka
(Lodz, Poland) |
| |
| 17:45-19:00 |
|
A PHASE 2 STUDY OF VORELOXIN AS SINGLE AGENT THERAPY FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
| 0302 |
| Ravandi, Farhad,
Stuart, Robert,
Maris, Michael,
Stone, Richard,
Cripe, Larry,
Cooper, Maureen,
Turturro, Francesco,
Stock, Wendy,
Strickland, Stephen,
Mahadocon, Kristi,
Fox, Judith,
Michelson, Glenn,
Berman, Craig
(Houston, United States of America) |
| |
| 17:45-19:00 |
|
LONG-TERM MOLECULAR COMPLETE REMISSION WITH PULSED ATRA AS SINGLE AGENT IN PML-RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA
| 0303 |
| Vigna, Ernesto,
Piccaluga, Pierpaolo,
Ottaviani, Emanuela,
Laterza, Claudio,
Malagola, Michele,
Rondoni, Michela,
Paolini, Stefania,
Morelli, Rosellina,
Finelli, Carlo,
Morabito, Fortunato,
Visani , Giuseppe,
Baccarani, Michele,
Martinelli, Giovanni
(Cosenza, Italy) |
| |
| 17:45-19:00 |
|
A LUMINESCENT WHOLE CELL BACTERIAL BIOSENSOR FOR RAPID PRE-SCREENING OF CHEMOTHERAPY EFFICACY
| 0304 |
| Anderson, Elizabeth,
Alloush, Habib,
Smith, Ann,
Smith, Graham,
Salisbury, Vyv
(Bristol, United Kingdom) |
| |
| 17:45-19:00 |
|
INDUCTION INTENSIFIED REGIMENS INCLUDING FLUDARABINE OR GEMTUZUMAB-OZOGAMICIN FOR ACUTE MYELOID LEUKEMIA PATIENTS: COMPARISON BY RESPONSE AND FOLLOW-UP
| 0305 |
| Papayannidis, Cristina,
Candoni, Anna,
Paolini, Stefania,
Ottaviani, Emanuela,
Iacobucci, Ilaria,
Rondoni, Michela,
Malagola, Michele,
Piccaluga, Pier Paolo,
Fanin, Renato,
Visani, Giuseppe,
Baccarani, Michele,
Russo, Domenico,
Martinelli, Giovanni
(Bologna, Italy) |
| |
| 17:45-19:00 |
|
PROGNOSTIC SIGNIFICANCE OF FLT3/ITD MUTATION AND ABCB1 GENE POLYMORPHISMS IN CORE BINDING FACTOR (CBF)-ACUTE MYELOID LEUKEMIA (AML)
| 0306 |
| Kim, Yeo-Kyeoung ,
Kim, Hee-Nam ,
Lee, Il-Kwon ,
Bang, Soo-Mee ,
Kim, Hee-Je ,
Jo, Deog-Yeon ,
Won, Jong-Ho ,
Kwak, Jae-Yong ,
Park, Moo-Rim ,
Ahn, Jae-Sook ,
Yang, Deok-Hwan ,
Lee, Je-Jung ,
Kim, Hyeoung-Joon
(Gwangju, South-Korea) |
| |
| 17:45-19:00 |
|
LAROMUSTINE INDUCES REMISSIONS IN ELDERLY POOR RISK AML PATIENTS WITH ADVERSE CYTOGENETICS AND DEMONSTRATES SIGNIFICANTLY IMPROVED SURVIVAL IN A HISTORICAL COMPARISON WITH PATIENTS TREATED IN THE UK NCRI AML14 TRIAL
| 0307 |
| Hills, Robert,
O'Brien, Susan,
Schiller, Gary,
Karsten, Verena,
Giles, Frank,
Burnett, Alan
(Cardiff, United Kingdom) |
| |
| 17:45-19:00 |
|
RASGRP1/APTX RATIO IS A STRONG BIOMARKER WHICH PREDICTS RESPONSE TO THERAPY WITH TIPIFARNIB PLUS BORTEZOMIB IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
| 0308 |
| Papayannidis, Cristina,
Paolini, Stefania,
Ottaviani, Emanuela,
Iacobucci, Ilaria,
Salmi, Federica,
Lama, Barbara,
Curti, Antonio,
Parisi, Sarah,
Cilloni, Daniela,
Saglio, Giuseppe,
Candoni, Anna,
Morabito, Fortunato,
Raponi, Mitch,
Baccarani, Michele,
Martinelli, Giovanni
(Bologna, Italy) |
| |
| 17:45-19:00 |
|
BODY MASS INDEX IS AN INDEPENDENT PREDICTOR OF DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
| 0309 |
| Jeddi, Ramzi,
Ghédira, Hela,
Mnif, Samia,
Ben Amor, Ramzi,
Aissaoui, Lamia,
Kacem, Karima,
Bouteraâ, Walid,
Ben Lakhal, Raihane,
Saad, Ali,
Ben Abid , Hela,
Belhadjali, Zaher,
Meddeb, Balkis,
Belhadjali, Zaher,
Belhadjali, Zaher
(Tunis, Tunisia) |
| |
| 17:45-19:00 |
|
A PHASE I STUDY WITH CP-4055 AND IDARUBICIN IN PATIENTS WITH REFRACTORY/RELAPSED AML
| 0310 |
| O'Brien, Susan,
Rizzieri, David,
Padmanabhan, Swaminathan,
Ravandi, Farhad,
Jacobsen, Tove Flem,
Staudacher, Karin,
Nilsson, Bo I.,
Giles, Francis J.
(Houston, United States of America) |
| |
| 17:45-19:00 |
|
CNS MANIFESTION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA SCHEDULED FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
| 0311 |
| Bommer, Martin,
Von Harsdorf, Stephanie,
Bunjes, Donald,
Doehner, Hartmut,
Ringhoffer, Mark
(Ulm, Germany) |
| |
| 17:45-19:00 |
|
FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT
| 0312 |
| Candoni, Anna,
Simeone, Erica,
Michelutti, Angela,
Damiani, Daniela,
Russo, Domenico,
Fanin, Renato
(Udine, Italy) |
| |
| 17:45-19:00 |
|
INDUCTION THERAPY WITH “3 7” CHEMOTHERAPY PLUS ATRA FOLLOWED BY CONSOLIDATIONS WITH THREE COURSES OF IDARUBICIN ALONE AND MAINTENANCE THERAPY WITH ATRA IN NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) HAS AN EXCELLENT LEUKEMIA-FREE SURVIVAL BUT MINIMAL TOXICITY IN LOW AND INTERMEDIATE RISK GROU
| 0313 |
| Mun, Yeung-Chul,
Choi, Moon Young,
Cho, Eun Kyung,
Lee, Jae Hoon,
Jo, Deog Yeon,
Kim, Inho,
Bang, Soo-Mee,
Yoon, Sung Soo,
Park, Seonyang,
Kim, Byoung Kook,
Kim, Hawk,
Min, Young Joo,
Park, Jae Hoo,
Seo, Jong Jin,
Moon, Hyung Nam,
Lee, Moon Hee,
Kim, Cheol Soo,
Lee, Won Sik,
Joo, Young Don,
Chung, So Young,
Oh, Doyeun,
Zang, Dae Young,
Lee, Kyung Hee,
Hyun, Myung Soo,
Song, Hong Suk,
Kim, Heung Sik ,
Kim, Sung Hyun ,
Kwon, Hyuk Chan ,
Kim, Hyo Jin,
Ahn, Myung Ju,
Ahn, Jin Seok,
Park, Yeon Hee ,
Park, Kyung Tae ,
Bae, Sung Hwa,
Ryoo, Hun-Mo,
Choi, Jung-Hye ,
Yoon, Hwi-Joong,
Nam, Seung-Hyun,
Kim, Bong-Seog ,
Seong, Chu-Myong
(Seoul, South-Korea) |
| |
| 17:45-19:00 |
|
MORPHOLOGIC AND MOLECULAR CHARACTERIZATION OF LEUKEMIC TUMORS IN THE BREAST: IMPLICATIONS FOR RESISTANCE TO CHEMOTHERAPY
| 0314 |
| Cunningham, Isabel,
Cordon-Cardo's
(New York, United States of America) |
| |
|